Gene therapy is controversial, but who said we need to modify human genes? Predicting the effects of gene editing is a long-awaited holy grail to drug research: Each living cell has many receptors, and activating or blocking different receptors causes the cell to act differently (or self-destruct). Several drugs work by mimicking the shape of these receptor-binding proteins.
But how do you develop a drug that binds to a particular receptor and requires a particular form? That's where the sort of AI that this startup claims to possess comes to play: it can simulate whether a particular new drug will have the right shape or not to bind to the target receptors. The instructions to create these drugs are then transferred to drug-producing factories (such as bacteria or other genetically modified cellular organisms), which secrete the drugs that are harvested for human use. A long way from human gene modification, but an important advancement in speeding up the development of new drugs that fall into this class of production!
This Startup Says AI Can Predict the Effects of Gene Editing
Can a Canadian startup with some big names attached set itself apart in the competitive world of bioinformatics?